Healthcare & Medical Devices Global On demand · 24-48h

Global Biopreservation Media Market Strategic Research Report

Global Biopreservation Media Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Biopreservation Media Market
$6142025
13%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Products of Animal Origin, Serum, Protein, Other

By Application: Stem Cell Research, Cell Therapy, Cancer Research, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BioLife Solutions, Lonza, Cellutions BioStorage, Lifeline Scientific Inc., STEMCELL Technologies, Princeton CryoTech Inc., VWR International, BioCision LLC, Azenta US, Cesca Therapeutics, Core Dynamics, Custom Biogenic Systems, Thermo Fisher Scientific, MVE Biological Solutions, Charles River, Merck Millipore, Sigma-Aldrich (MilliporeSigma), Corning Life Sciences

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 138 pages
Market size 2025
$614
Million USD
Forecast CAGR
13%
2025-2032
Forecast 2032
$1444.5
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Biopreservation Media market size is predicted to grow from US$ 614 million in 2025 to US$ 1,421 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.

Biopreservation Media are specialized culture media and cryopreservation solutions used to preserve cells, tissues, and organs for long-term storage, transport, and transplantation. In 2024, the global average price of biopreservation media is approximately US$175 per liter, with worldwide shipments reaching about 3.2 million liters. Gross margins typically range from 30%–50%, driven by the complexity of formulation, regulatory requirements, raw material quality, and advancements in cryopreservation techniques. The supply chain includes upstream media components (such as amino acids, vitamins, and cryoprotectants), raw materials, high-quality plastics for containers, and packaging materials; midstream manufacturers formulate media, conduct quality control and validation, and provide packaging; downstream customers include cell therapy companies, vaccine developers, biopharmaceutical manufacturers, academic research institutions, and hospitals.

The biopreservation media market is experiencing strong growth, driven by increasing demand for cell-based therapies, regenerative medicine, and vaccine development. With the rise of personalized medicine and cell therapy applications, the need for high-quality preservation solutions to ensure cell viability during storage and transport has surged. Advances in cryopreservation technology and improved media formulations continue to drive innovation in the market, leading to sustained growth through 2031.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biopreservation Media market?

What factors are driving Biopreservation Media market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biopreservation Media market opportunities vary by end market size?

How does Biopreservation Media break out by Type, by Application?

This report presents a comprehensive overview of the global Biopreservation Media market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Products of Animal Origin
  • Serum
  • Protein
  • Other

Segment by Media Type

  • Cryopreservation Media
  • Stem Cell Preservation Media
  • Cell Culture Media
  • Transport Media
  • Serum-Free Media

Segment by Cryoprotectant Type

  • Dimethyl Sulfoxide (DMSO)
  • Glycerol-Based Cryoprotectants
  • Protein-Based Cryoprotectants
  • Non-DMSO Cryoprotectants

Segment by Application

  • Stem Cell Research
  • Cell Therapy
  • Cancer Research
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biopreservation Media market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Stem Cell Research, Cell Therapy, Cancer Research evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Biopreservation Media Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 13%
Regional growth momentum
Market share by segment
Key metrics
Base value
$614
2025
Forecast
$1444.5
2032
CAGR
13%
2025–2032
Gebieden
5
global
Key companies
BioLife SolutionsLonzaCellutions BioStorageLifeline Scientific Inc.STEMCELL TechnologiesPrinceton CryoTech Inc.VWR InternationalBioCision LLC
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Products of Animal OriginSerumProteinOther
By Application
Stem Cell ResearchCell TherapyCancer ResearchOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Products of Animal Origin
  • 3.1.3 Serum
  • 3.1.4 Protein
  • 3.1.5 Other
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Stem Cell Research
  • 4.1.3 Cell Therapy
  • 4.1.4 Cancer Research
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BioLife Solutions
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Lonza
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cellutions BioStorage
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Lifeline Scientific Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 STEMCELL Technologies
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Princeton CryoTech Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 VWR International
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 BioCision LLC
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Azenta US
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Cesca Therapeutics
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Core Dynamics
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Custom Biogenic Systems
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Thermo Fisher Scientific
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 MVE Biological Solutions
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Charles River
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Merck Millipore
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Sigma-Aldrich (MilliporeSigma)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Corning Life Sciences
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Biopreservation Media market?
The global Biopreservation Media market is estimated at US$ 614 million in 2025 (base year) and is projected to reach US$ 1.42 billion by 2032.
What is the forecast CAGR for the Biopreservation Media market?
The market is expected to grow at a CAGR of 13.0% from 2026 to 2032, expanding from US$ 614 million in 2025 to US$ 1.42 billion in 2032, roughly 2.3 times its base-year value.
What is Biopreservation Media?
Biopreservation Media are specialized culture media and cryopreservation solutions used to preserve cells, tissues, and organs for long-term storage, transport, and transplantation. In 2024, the global average price of biopreservation media is approximately US$175 per liter, with worldwide shipments reaching about 3.2 million liters. Gross margins typically range from 30%–50%, driven by the complexity of formulation, regulatory requirements, raw material quality, and advancements in cryopreservation techniques.
How is the Biopreservation Media market segmented by type?
By type, the market is segmented into Products of Animal Origin, Serum, Protein and Other.
What are the key applications of Biopreservation Media?
Key applications covered include Stem Cell Research, Cell Therapy, Cancer Research and Other.
Which companies are profiled in the Biopreservation Media market report?
Key players profiled include BioLife Solutions, Lonza, Cellutions BioStorage, Lifeline Scientific Inc., STEMCELL Technologies, Princeton CryoTech Inc., VWR International and BioCision LLC, among 18 companies covered in total.
What geographies does the Biopreservation Media market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Biopreservation Media?
The biopreservation media market is experiencing strong growth, driven by increasing demand for cell-based therapies, regenerative medicine, and vaccine development.
Who should buy the Biopreservation Media market report?
The report is intended for manufacturers and solution providers, distributors and end users in Stem Cell Research, Cell Therapy and Cancer Research, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biopreservation Media market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.